Hemophilic Arthropathy
9
0
0
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
22.2%
2 terminated out of 9 trials
77.8%
-8.7% vs benchmark
11%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Kinesiophobia in the Parents of Hemophilia Patients
Vitamin D Deficiency and Body Composition in the Patients With Hemophilia
Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy
Efficacy and Safety of Shea Nut Oil in Hemophilic Arthropathy
The Effects of Exercises on Gait in Hemophilic Individuals
Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy
Sarcopenia and Osteoporosis in the Patients With Hemophilia
A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy
Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and Ankles